What is the appropriate diagnostic work‑up and treatment for a patient presenting with both uveitis and a pulmonary abscess?

Diagnostic Work-Up and Treatment for Uveitis with Pulmonary Abscess

The combination of uveitis and pulmonary abscess demands immediate exclusion of infectious etiologies—particularly tuberculosis and disseminated Mycobacterium abscessus—before any immunosuppressive therapy is initiated.

Critical Diagnostic Priority: Rule Out Infection First

When confronted with this dual presentation, treatment nonadherence, infections, and masquerade syndromes must be considered before any change in therapy 1. This is a Grade B recommendation that takes precedence over all other considerations.

Essential Infectious Work-Up

Before initiating any immunosuppressive therapy for uveitis, you must:

• Tuberculosis screening (mandatory): Interferon-gamma release assay (IGRA) and tuberculin skin testing 2, 3, 4
• Chest CT imaging to characterize the pulmonary abscess and evaluate for TB or other mycobacterial disease 2, 3
• Syphilis serology (the only universal screening test appropriate for all forms of uveitis) 2, 3
• HIV testing before initiating biologic therapy 1
• Sputum cultures and pleural fluid analysis if accessible, specifically testing for Mycobacterium tuberculosis and M. abscessus 5, 4

The rationale is critical: M. abscessus disseminated infections can mimic sarcoidosis and present with both uveitis and pulmonary disease 5. Missing this diagnosis while initiating immunosuppression could be catastrophic.

Specific Uveitis Characterization

Characterize the uveitis by:

• Anatomic location (anterior, intermediate, posterior, or panuveitis)
• Course (acute vs. chronic—defined as ≥3 months duration) 6
• Laterality (unilateral vs. bilateral)
• Presence of granulomatous features 7, 8

For chronic uveitis with pulmonary findings, additional testing includes:

• Serum angiotensin-converting enzyme (for sarcoidosis) 2, 3
• HLA-B27 only if unilateral acute anterior non-granulomatous uveitis 2, 3
• Cerebral MRI and anterior chamber tap with IL-10 analysis if intermediate/posterior uveitis in patients >40 years (to exclude lymphoma masquerade) 2, 3

Treatment Algorithm

If Infectious Etiology Confirmed

For M. abscessus pulmonary disease with disseminated infection:

• Macrolide-based multidrug regimen with at least 3 active drugs (strong recommendation) 9
• Macrolides are recommended for strains without inducible/mutational resistance 9
• Expert consultation is mandatory given the complexity and high mortality risk 9
• Do not use systemic corticosteroids alone until antimicrobial coverage is established 4

For tuberculous uveitis:

• Antituberculosis treatment is mandatory 4
• Avoid glucocorticoids in isolation 4
• Body temperature and inflammatory markers should normalize with appropriate antimicrobial therapy 4

If Noninfectious Etiology Confirmed

Only after excluding infection through the above work-up:

For anterior uveitis:

• Topical corticosteroids as first-line 10

For moderate-to-severe intermediate, posterior, or panuveitis:

• These are sight-threatening and require systemic therapy 10
• First-line: Disease-modifying antirheumatic drugs (methotrexate achieves remission in 52.1% of posterior uveitis; mycophenolate mofetil controls inflammation in 70.9%) 10
• Second-line: Adalimumab if refractory to first-line therapy (extends time to treatment failure from 13 to 24 weeks) 10

Baseline testing before immunosuppression (Grade C recommendation) 1:

• Vital organ function assessment
• Screening for latent infections that may reactivate
• History of malignancy, hepatitis, or tuberculosis 1

Critical Pitfalls to Avoid

1. Never initiate immunosuppression without excluding infection—this is the most dangerous error in this clinical scenario
2. Do not dismiss the pulmonary abscess as unrelated—disseminated M. abscessus can cause both findings 5
3. Do not rely on isolated glucocorticoid therapy if TB is suspected or confirmed 4
4. Do not order unfocused laboratory panels—investigations without clinical orientation are almost always unhelpful 2, 3
5. Recognize that positive IGRA with unexplained uveitis warrants antituberculosis treatment after excluding other causes 4

When Diagnosis Remains Unclear

If the work-up is negative and uveitis persists, designate as "undifferentiated [bilateral/unilateral] [chronic/acute] [anatomic location] uveitis" rather than "idiopathic" 8. Continue monitoring and consider diagnostic vitrectomy if masquerade syndrome (particularly lymphoma) remains a concern 1.